Bsx nyse.

The stock of Boston Scientific Corp. (NYSE: BSX) has decreased by -2.10 when compared to last closing price of 56.14.Despite this, the company has seen a loss of -1.31% in its stock price over the last five trading days. InvestorPlace reported 2023-11-28 that With their robustness and growth potential, healthcare stocks are becoming a focal ...

Bsx nyse. Things To Know About Bsx nyse.

MARLBOROUGH, Mass., Oct. 6, 2021 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. The acquisition will expand the Boston Scientific electrophysiology and ...Nov 17, 2023 · The public float for BSX is 1.46B, and at present, short sellers hold a 0.63% of that float. On November 17, 2023, the average trading volume of BSX was 8.51M shares. BSX) stock’s latest price update. Boston Scientific Corp. (NYSE: BSX) has seen a rise in its stock price by 1.52 in relation to its previous close of 53.85. Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.079 = US$2.3b ÷ (US$34b - US$4.6b) (Based on the trailing twelve months to September ...WebOn October 18, 2023, Boston Scientific Corporation (NYSE:BSX) stock closed at $50.71 per share. One-month return of Boston Scientific Corporation (NYSE:BSX) was -5.82%, and its shares gained 26.35 ...

MARLBOROUGH, Mass., Jan. 21, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Preventice Solutions, Inc., a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors – including short and …WebReturn on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.079 = US$2.3b ÷ (US$34b - US$4.6b) (Based on the …Get Our Latest Report on BSX. Boston Scientific Stock Up 0.4 %. Shares of NYSE:BSX traded up $0.25 on Friday, reaching $56.14. The company had a trading volume of 4,730,456 shares, compared to its ...

BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR THIRD QUARTER 2023. MARLBOROUGH, Mass. , Oct. 26, 2023 /PRNewswire/ -- Boston Scientific …Boston Scientific (NYSE: BSX) ... BSX stock is trading at 27x forward P/E based on our earnings forecast of $1.92 for 2023, compared to the last three-year average of 24x, implying that BSX stock ...

Boston Scientific Corporation (NYSE:BSX) entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. (NasdaqGM:APEN) for approximately $440 million. Nov 30 Boston Scientific Corporation Announces the First Results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) StudyDec 1, 2023BSX Boston Scientific Corporation MORNING UPDATE: Man Securities Issues Alerts for AMD, BSX, AAPL, QLGC, And RMBSWebFOURTH QUARTER AND FULL YEAR 2022. Marlborough, Mass. (February 1, 2023) -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational 1 basis and 7.1 percent on an organic 2 basis, all compared to the prior year …Web

On Oct 26, 2023, Boston Scientific ( NYSE: BSX) reported Q3 2023 earnings per share (EPS) of $0.34, up 183.33% year over year. Total Boston Scientific earnings for the quarter were $505.00 million. In the same quarter last year, Boston Scientific 's earnings per share (EPS) was $0.12. If you're new to stock investing, here's how to buy Boston ...Web

BSX - Boston Scientific Corp. Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)

Boston Scientific Corp stock price (BSX) NYSE: BSX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Boston Scientific Corp stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.Their BSX share price targets range from $55.00 to $66.00. On average, they anticipate the company's share price to reach $60.55 in the next year. This suggests a possible upside of 8.7% from the stock's current price. View analysts price targets for BSX or view top-rated stocks among Wall Street analysts.Feb 3, 2023 · MARLBOROUGH, Mass., Feb. 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LithoVue™ Elite Single ... The latest price target for . Boston Scientific (NYSE: BSX) was reported by Canaccord Genuity on Monday, November 27, 2023.The analyst firm set a price target for 64.00 expecting BSX to rise to ... MARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64 percent) of M.I.Tech Co., Ltd, ("M.I.Tech") a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures.

Sep 1, 2021 · MARLBOROUGH, Mass., Sept. 1, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced the close of its acquisition of the global surgical business of Lumenis LTD., a privately-held ... MARLBOROUGH, Mass., Feb. 2, 2022 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.127 billion during the fourth quarter of 2021, growing 15.4 percent on a reported basis, 16.9 percent on an operational 1 basis and 15.1 percent on an organic 2 basis, all compared to the prior year period.The latest Boston Scientific stock prices, stock quotes, news, and BSX history to help you invest and trade smarter. ... After-market 07:27:17 PM EDT 12/1/2023 NYSE. Start Trading.Abbott (NYSE: ABT), Boston Scientific (NYSE: BSX) and Medtronic (NYSE: MDT) are the most likely potential buyers of ShockWave Medical (NASDAQ: SWAV) after a report late Friday that the company has ...The latest price target for . Boston Scientific (NYSE: BSX) was reported by Canaccord Genuity on Monday, November 27, 2023.The analyst firm set a price target for 64.00 expecting BSX to rise to ... Dec 11, 2022 · MARLBOROUGH, Mass., Dec. 11, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional ... Nov 27, 2023 · Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Neuromodulation. I.

Ken Griffin raised his stake in Boston Scientific Corporation (NYSE:BSX) by 16% in Q3 2022, holding 14.5 million shares worth $561.25 million, representing 0.12% of the total 13F securities.Find the latest Blackstone Minerals Limited (BSX.AX) stock quote, history, news and other vital information to help you with your stock trading and investing.

1. Confirmed cup and handle pattern on BSX chart Hi, please see the following chart pattern, that has been confirmed in the last weeks. Accordingly to the rules of the pattern, the …The public float for BSX is 1.46B, and at present, short sellers hold a 0.63% of that float. On November 17, 2023, the average trading volume of BSX was 8.51M shares. BSX) stock’s latest price update. Boston Scientific Corp. (NYSE: BSX) has seen a rise in its stock price by 1.52 in relation to its previous close of 53.85.Tax Effect of Unusual Items. -68,632. -149,867. -20,944. -221,670. -60,210. Get the detailed quarterly/annual income statement for Boston Scientific Corporation (BSX). Find out the revenue ...Dec 4, 2023 · Mount Lucas Management LP bought a new position in Boston Scientific Co. (NYSE:BSX – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC.The ... Boston Scientific Revenue. Boston Scientific had revenue of $13.40B in the twelve months ending June 30, 2023, with 8.69% growth year-over-year. Revenue in the quarter ending June 30, 2023 was $3.60B with 10.94% year-over-year growth. In the year 2022, Boston Scientific had annual revenue of $12.68B with 6.68% growth.WebMARLBOROUGH, Mass., Sept. 6, 2018 / PRNewswire / -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Augmenix, Inc., a privately-held company which has developed and commercialized the SpaceOAR ® System, a therapy used to reduce common and debilitating side effects …Web

Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.389 billion during the first quarter of 2023, growing 12.0 percent on a reported basis, 14.9 percent on an operational1 basis ...

Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Neuromodulation. I.

Earnings for Boston Scientific are expected to grow by 10.95% in the coming year, from $2.01 to $2.23 per share. Boston Scientific has not formally confirmed its next …Get real-time Boston Scientific (BSX) stock price quotes, analyst insights ... Tech Sector Has Lots to Prove as Earnings Loom Following Strong Q1 Stock Market.In certain circumstances, securities with respect to which the relevant exchange has commenced delisting proceedings may continue to be traded pending appeal of that …For the full year, Boston Scientific Corporation (NYSE:BSX) lowered its adjusted earnings outlook to a range of $1.71 – $1.74 per share, from its previous guidance between $1.74 – $1.77 per share.Research Boston Scientific's (NYSE:BSX) stock key valuation metrics while comparing it with its industry peers & market side by side./PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a... BSX: 51.56 (+0.25%) Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device PR Newswire - Wed Sep 6, 3:00PM CDTWebAniversário do 2º CPM. fevereiro 10, 2023. No dia 08 de dezembro de 2022, foi realizada a Solenidade Militar de Entrega de Comando do 2º Colégio da Polícia Militar do Paraná, …Find the latest Boston Scientific Corporation (BSX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Real time Boston Scientific (BSX) stock price quote, stock graph, news & analysis. A high-level overview of Boston Scientific Corporation (BSX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.0.73%. $23.63B. Teleflex Inc. 0.65%. $10.33B. BSX | Complete Boston Scientific Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Instagram:https://instagram. vanguard federal money market interest ratedebit card instantbest free tax software for self employednasdaq mu financials The company's devices are marketed globally to healthcare professionals and institutions, with foreign sales accounting for nearly half of its total sales. Currently, Boston Scientific ( NYSE:BSX ... amazon tankingnfl doctor Find the latest Boston Scientific Corporation (BSX) stock quote, history, news and other vital information to help you with your stock trading and investing. ishares sgov MARLBOROUGH, Mass., Sept. 1, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced the close of its acquisition of the global surgical business of Lumenis LTD., a privately-held ...14. Boston Scientific Corporation (NYSE: BSX) Value of Point72 Asset Management’s 13F Position: $188.8 million. Number of Hedge Fund Shareholders: 71. Boston Scientific Corporation (NYSE:BSX) is ...